Pitt-Hopkins Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 26 July 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
In vitro effects of pH variation and immune-induced copper accumulation on the antibacterial and cytotoxic activity of levofloxacin during Streptococcus pneumoniae infection.
Labović Miljana et al. — Bioorganic chemistry (15 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42127742/
- 2.
Intrinsically disordered bHLH family member TCF4 drives phase separation in a DNA-dependent manner.
Sozańska Nikola et al. — Archives of biochemistry and biophysics (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42106138/
- 3.
Sleep complaints and genetic risk of Alzheimer's disease in older women: associations with memory and tau deposition.
Lui Kitty K et al. — The journal of prevention of Alzheimer's disease (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42096939/
- 4.
Critical review of the influence of charge-assisted hydrogen bonding on fate, transport, and treatment of representative contaminants of emerging concern and natural organic matter.
Li Xiaoyun et al. — Journal of hazardous materials (15 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42160934/
- 5.
Ligand-controlled engineering of Cu-H active sites on Cu
Xiang Zongchen et al. — Nanoscale (3 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42396837/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Pitt-Hopkins Syndrome
Pitt-Hopkins syndrome is a rare neurodevelopmental condition caused by mutations in the TCF4 gene, causing intellectual disability, absent speech, characteristic facial features, and distinctive breathing abnormalities. Diagnosis has increased with molecular genetic testing. Research into TCF4 restoration strategies is emerging.
Most Recent Research
Copper is an essential trace redox active metal and its concentration in human body is increased during infections. Given the potential for copper ions to modulate antibiotic activity, this study investigates the interactions between Cu2+ and levofloxacin (LVX) in vitro, under pH conditions representative of S. pneumoniae-induced pneumonia, with subsequent assessment of the resulting antibacterial and cytotoxic effects. Complex formation between Cu2+ and LVX is observed at both, physiological (pH 7.4), as well as in acidic conditions (pH 4) associated with the metabolic activity of S. pneumoniae. At both investigated pHs monoligand and bisligand Cu2+ complexes of LVX were detected by UV-Vis, EPR and cyclic voltammetry. Their abundance depends on pH and molar ratio of LVX and Cu2+. The physiological pH 7.4 and higher LVX/Cu2+ molar ratios shift equilibrium toward formation of bisligand complex. In both complexes Cu2+ coordinates with LVX through the carboxylic and β-keto oxygen atoms. The effect of Cu2+ coordination with LVX on its antibacterial and cytotoxic activity were investigated. Formation of Cu2+-LVX complexes enhance antibacterial activity of LVX against S. pneumoniae, E. coli, and K. pneumoniae at both pH values, but reduce activity against S. aureus compared to LVX alone. Additionally, Cu2+-LVX complexes exhibit higher cytotoxicity toward normal lung fibroblasts than A549 carcinoma cells with a more pronounced effect under acidic conditions. In vitro evaluation of antibacterial and cytotoxic activity of LVX in the presence of Cu2+ ions highlights the Janus-faced behavior of the Cu2+-LVX complexes, characterized by simultaneous beneficial improvement of antimicrobial activity and harmful cytotoxicity to lung fibroblasts.
Common Questions
What is Pitt-Hopkins Syndrome?
Pitt-Hopkins syndrome is a rare neurodevelopmental condition caused by mutations in the TCF4 gene, causing intellectual disability, absent speech, characteristic facial features, and distinctive breathing abnormalities. Diagnosis has increased with molecular genetic testing. Research into TCF4 restoration strategies is emerging.
How many clinical trials are available for Pitt-Hopkins Syndrome?
No clinical trials are currently indexed for Pitt-Hopkins Syndrome. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Pitt-Hopkins Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Pitt-Hopkins Syndrome.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.